Showing results (2411-2420 of 2,814) with videos related to

Sort By:
Pageof 282
Plos Medicine|May 11, 2006
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPsNancy J Sullivan, Thomas W Geisbert, Joan B Geisbert, et al.
Genome Biology and Evolution|November 6, 2013
Genomic evolution of the pathogenic Wolbachia strain, wMelPopMegan Woolfit, Iñaki Iturbe-Ormaetxe, Jeremy C Brownlie, et al.
Plos Pathogens|April 8, 2021
High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19Sung Hee Ko, Elham Bayat Mokhtari, Prakriti Mudvari, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
A Single-shot ChAd3 Vaccine Provides Protection from Intramuscular and Aerosol Sudan Virus ExposureAnna N Honko, Ruth Hunegnaw, Juan I Moliva, et al.
Eclinicalmedicine|January 29, 2020
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysisMary Thompson, Shirley H J Mei, Dianna Wolfe, et al.
The Journal of Infectious Diseases|January 13, 2018
Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the CongoSabue Mulangu, Vivian H Alfonso, Nicole A Hoff, et al.
JAMA Network Open|May 3, 2024
Cumulative Systolic Blood Pressure and Incident Stroke Type Variation by Race and EthnicityKimson E Johnson, Hanyu Li, Min Zhang, et al.
Developmental Cell|May 24, 2017
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell ProliferationHuayang Liu, James A Dowdle, Safiya Khurshid, et al.
Investigational New Drugs|January 3, 2021
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancersJ Wu, D Liu, M Offin, et al.
Kidney International Reports|October 26, 2020
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 InhibitorsHarish Seethapathy, Sophia Zhao, Ian A Strohbehn, et al.
Pageof 282